| Company Name | Announcement |
|---|---|
|
Aavas Financiers Limited
Aavas Financiers Limited [27-Oct-2026] |
Aavas Financiers Limited has informed the Exchange about Copies of Newspaper Clippings of Unaudited Financial Results for the Quarter and Half Year ended September 30, 2026 |
|
Aditya Birla Real Estate Limited
Aditya Birla Real Estate Limited [27-Oct-2026] |
Aditya Birla Real Estate Limited has informed the Exchange about Copy of Newspaper Publication of Unaudited Financial Results for the quarter ended 30th September, 2026. |
|
Aditya Birla Sun Life AMC Limited
Aditya Birla Sun Life AMC Limited [27-Oct-2026] |
Aditya Birla Sun Life AMC Limited has informed the Exchange about Transcript of Earnings Conference Call on Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2026 |
|
ACC Limited
ACC Limited [27-Oct-2026] |
ACC Limited has informed the Exchange regarding a press release dated October 27, 2026, titled "ACC Builds Momentum with Improved Trade Mix, Capacity Expansion and Progress on One Cement Platform". |
|
Acutaas Chemicals Limited
Acutaas Chemicals Limited [27-Oct-2026] |
Acutaas Chemicals Limited has informed the Exchange about Investor Presentation |
|
Aequs Limited
Aequs Limited [27-Oct-2026] |
Submission of copies of newspaper publications regarding the statement of Un-audited Financial Results (Standalone and Consolidated) of the Company for the quarter and half year ended September 30, 2026 |
|
Allcargo Global Limited
Allcargo Global Limited [27-Oct-2026] |
Allcargo Global Limited has informed the Exchange regarding Monthly Business Updates for the month of September 2026 |
|
Akshar Spintex Limited
Akshar Spintex Limited [27-Oct-2026] |
Akshar Spintex Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. |
|
APL Apollo Tubes Limited
APL Apollo Tubes Limited [27-Oct-2026] |
APL Apollo Tubes Limited has informed the Exchange about Copy of Newspaper Publication |
|
Alembic Pharmaceuticals Limited
Alembic Pharmaceuticals Limited [27-Oct-2026] |
Alembic Pharmaceuticals Limited receives USFDA Final Approval for Valganciclovir for Oral Solution, 50 mg/mL. |
Old Backoffice
Data available till FY 2024-25 (Historical)
New Backoffice
Data From FY 2025-26 onwards (Latest)
